Nanohumps Biosciences Oy
Pioneering revolutionary cancer therapies using proprietary nanosized antibodies.
Översikt
- Okänt
- Anställda
- Okänt
- Omsättning
- 2023
- Grundat
Kontakter
Saara Saaralaulumaa
Beskrivning
Nanohumps is a pioneering organization focused on developing revolutionary cancer therapies. They specialize in utilizing proprietary nanosized antibodies, known as NanoAbs, as their core technology. The company's primary mission is to overcome the significant limitations associated with current ant...
Taggar
Nyckelord
Teknikstack
Företagsinformation
- Bransch
- Okänt
- Juridisk form
- 16
- Momsnummer
- FI34074921
Kontakter
1 kontakter i FunnelfeedrSaara Saaralaulumaa
Liknande företag
20 liknande företag i Funnelfeedr
AAX Biotech AB
5–9 anställdaResearch-driven biotech advancing antibody therapies via proprietary technology.
Solid Immuno-Oncology Oy
Developing organ-on-chip technology for advanced cancer treatment decisions.
Roche Oy
Leading global company developing innovative medicines and diagnostics.
Valo Therapeutics Oy
Developing novel peptide-coated oncolytic virus immunotherapies for cancer.
CANTARGIA AB
20–49 anställdaDeveloping antibody-based drugs targeting IL1RAP for serious diseases.
Utforska mer
Frågor om Nanohumps Biosciences Oy
Vill du se Funnelfeedr i praktiken?
Boka en gratis demo och upptäck hur Funnelfeedr hjälper dig att hitta och konvertera dina idealkunder.
Boka en demo